MedTrace Logo

PRF+1% MF for Class II Mandibular Furcation Defects

NCT03207698 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2017-07-05

No results posted yet for this study

Summary

The aim of the present trial is to evaluate the efficacy of PRF with 1% MF in treatment of mandibular class II furcation defects and its comparison to PRF and access therapy alone.

Conditions

  • Furcation Defects

Interventions

PROCEDURE

Open flap debridement (OFD)

Open flap debridement (OFD) alone

PROCEDURE

OFD with Platelet rich fibrin (PRF)

Open flap debridement (OFD) with Platelet rich fibrin (PRF) placement

PROCEDURE

OFD with Platelet rich fibrin (PRF)+1% Metformin (Drug) in gel form

Open flap debridement (OFD) with Platelet rich fibrin (PRF)+1.2% Atorvastatin gel placement

Sponsors & Collaborators

  • Government Dental College and Research Institute, Bangalore

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03207698 on ClinicalTrials.gov